- Citations, last 5 years
- 13.8k
- Works, last 5 years
- 2 014
- h-index
- 580
- Scientists listed
- 0
- Grants since 2016
- 630
Grants received
2021–2026 · program · P50
SPORE in Skin Cancer
Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
Chi V. Dang · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Drugging EBNA1 to Treat EBV-Associated Cancers
Troy E Messick · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Drugging EBNA1 to Treat EBV-Associated Cancers
Troy E Messick · The Wistar Institute · funded by National Institutes of Health
2021–2023 · research · R01
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib
Dario C Altieri · The Wistar Institute · funded by National Institutes of Health
2021–2023 · research · R01
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib
Dario C Altieri · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Drugging EBNA1 to Treat EBV-Associated Cancers
Troy E Messick · The Wistar Institute · funded by National Institutes of Health
2021–2025 · research · R00
dsRNA production and sensing during DNA virus infection
Alexander Matthew Price · The Wistar Institute · funded by National Institutes of Health
2021–2025 · grant · Standard Grant
Expansion, Curriculum Evolution, and Enhancement of Biotechnician Training
Kristy Mcguire · The Wistar Institute · funded by National Science Foundation
2021–2022 · research · R01
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
Chi V. Dang · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Regulation of EBV Latency by Purine Metabolism and Signaling
Italo Tempera · The Wistar Institute · funded by National Institutes of Health
2021–2023 · research · R21
The role of gut microbe-derived choline metabolites in driving the pro-inflammatory macrophage phenotype and restricting pancreatic cancer
Rahul Suresh Shinde · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
SPORE in Skin Cancer
Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Drugging EBNA1 to Treat EBV-Associated Cancers
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2021–2023 · research · R21
Development of Broad Coronavirus Immunity Targeting the Fusion Peptide
Daniel Kulp · The Wistar Institute · funded by National Institutes of Health
2021–2022 · grant · S10
Purchase of an Echo 650 acoustic liquid handler with Access workstation
Joseph M Salvino · The Wistar Institute · funded by National Institutes of Health
2021–2025 · research · R01
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans
Daniel Thomas Claiborne · The Wistar Institute · funded by National Institutes of Health
2021–2026 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2021–2025 · research · R01
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans
Daniel Thomas Claiborne · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · Global Health
Wistar Institute of Anatomy & Biology - to generate model systems to accelerate HIV vaccine design
The Wistar Institute · funded by Bill and Melinda Gates Foundation
2021–2023 · research · R21
Development of Broad Coronavirus Immunity Targeting the Fusion Peptide
Daniel Kulp · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
SPORE in Skin Cancer
Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2021–2025 · research · R01
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans
Daniel Thomas Claiborne · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Regulation of EBV Latency by Purine Metabolism and Signaling
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2021–2025 · research · Global Health
Wistar Institute of Anatomy & Biology - to discover circulating markers to determine the size and or quality of the HIV reservoir in the body
The Wistar Institute · funded by Bill and Melinda Gates Foundation
2021–2024 · research · R01
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R00
Integrated analyses of the epigenome to understand the molecular basis of hematopoietic malignancies
Avi Srivastava · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Therapeutic targeting MDSC-mediated immune suppression in cancer
Valerian E Kagan · The Wistar Institute · funded by National Institutes of Health
2021–2023 · career development · K22
Overcoming the hurdles to successful CAR T cell therapy for a functional HIV cure
Daniel Thomas Claiborne · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Regulation of EBV Latency by Purine Metabolism and Signaling
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Drugging EBNA1 to Treat EBV-Associated Cancers - Diversity Supplement
Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Regulation of EBV Latency by Purine Metabolism and Signaling
Italo Tempera · The Wistar Institute · funded by National Institutes of Health
2021–2025 · research · R00
dsRNA production and sensing during DNA virus infection
Alexander Matthew Price · The Wistar Institute · funded by National Institutes of Health
2021 · award
Elucidating the metabolic demands of immune evasion in breast cancer
Katelyn Miller · The Wistar Institute · funded by American Cancer Society
2021–2026 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2021–2026 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Drugging EBNA1 to Treat EBV-Associated Cancers
Troy E Messick · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Therapeutic targeting MDSC-mediated immune suppression in cancer
Valerian E Kagan · The Wistar Institute · funded by National Institutes of Health